Industry Research Reports

Home > Reports > Pharma & Healthcare > Tagrisso (Osimertinib) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Tagrisso (Osimertinib) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 101 Pages

Report ld: 3028346

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Tagrisso, also known by its generic name Osimertinib, is a medication used to treat certain types of non-small cell lung cancer (NSCLC). It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs), which work by blocking the action of certain proteins involved in the growth and spread of cancer cells. Tagrisso is specifically used for the treatment of NSCLC that has certain mutations in the epidermal growth factor receptor (EGFR) gene.

The global market for Tagrisso (Osimertinib) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Tagrisso (Osimertinib) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tagrisso (Osimertinib) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Tagrisso (Osimertinib) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Tagrisso (Osimertinib) include AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited and Drug International Limited, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Tagrisso (Osimertinib), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tagrisso (Osimertinib) by region & country, by Type, and by Application.

The Tagrisso (Osimertinib) market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tagrisso (Osimertinib).

Market Segmentation

Report Metric
Details
Report Title
Tagrisso (Osimertinib) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Tagrisso (Osimertinib) Companies Covered
AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited, Drug International Limited
Global Tagrisso (Osimertinib) Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tagrisso (Osimertinib) Market, Segment by Type
40 mg

80 mg
Global Tagrisso (Osimertinib) Market, Segment by Application
Locally Advanced NSCLC

Metastatic NSCLC

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tagrisso (Osimertinib) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Tagrisso (Osimertinib) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Tagrisso (Osimertinib) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Tagrisso (Osimertinib) Product Introduction
    1.2 Global Tagrisso (Osimertinib) Market Size Forecast
        1.2.1 Global Tagrisso (Osimertinib) Sales Value (2019-2030)
        1.2.2 Global Tagrisso (Osimertinib) Sales Volume (2019-2030)
        1.2.3 Global Tagrisso (Osimertinib) Sales Price (2019-2030)
    1.3 Tagrisso (Osimertinib) Market Trends & Drivers
        1.3.1 Tagrisso (Osimertinib) Industry Trends
        1.3.2 Tagrisso (Osimertinib) Market Drivers & Opportunity
        1.3.3 Tagrisso (Osimertinib) Market Challenges
        1.3.4 Tagrisso (Osimertinib) Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Tagrisso (Osimertinib) Players Revenue Ranking (2023)
    2.2 Global Tagrisso (Osimertinib) Revenue by Company (2019-2024)
    2.3 Global Tagrisso (Osimertinib) Players Sales Volume Ranking (2023)
    2.4 Global Tagrisso (Osimertinib) Sales Volume by Company Players (2019-2024)
    2.5 Global Tagrisso (Osimertinib) Average Price by Company (2019-2024)
    2.6 Key Manufacturers Tagrisso (Osimertinib) Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Tagrisso (Osimertinib) Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Tagrisso (Osimertinib)
    2.9 Tagrisso (Osimertinib) Market Competitive Analysis
        2.9.1 Tagrisso (Osimertinib) Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Tagrisso (Osimertinib) Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tagrisso (Osimertinib) as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 40 mg
        3.1.2 80 mg
    3.2 Global Tagrisso (Osimertinib) Sales Value by Type
        3.2.1 Global Tagrisso (Osimertinib) Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Tagrisso (Osimertinib) Sales Value, by Type (2019-2030)
        3.2.3 Global Tagrisso (Osimertinib) Sales Value, by Type (%) (2019-2030)
    3.3 Global Tagrisso (Osimertinib) Sales Volume by Type
        3.3.1 Global Tagrisso (Osimertinib) Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Tagrisso (Osimertinib) Sales Volume, by Type (2019-2030)
        3.3.3 Global Tagrisso (Osimertinib) Sales Volume, by Type (%) (2019-2030)
    3.4 Global Tagrisso (Osimertinib) Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Locally Advanced NSCLC
        4.1.2 Metastatic NSCLC
        4.1.3 Other
    4.2 Global Tagrisso (Osimertinib) Sales Value by Application
        4.2.1 Global Tagrisso (Osimertinib) Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Tagrisso (Osimertinib) Sales Value, by Application (2019-2030)
        4.2.3 Global Tagrisso (Osimertinib) Sales Value, by Application (%) (2019-2030)
    4.3 Global Tagrisso (Osimertinib) Sales Volume by Application
        4.3.1 Global Tagrisso (Osimertinib) Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Tagrisso (Osimertinib) Sales Volume, by Application (2019-2030)
        4.3.3 Global Tagrisso (Osimertinib) Sales Volume, by Application (%) (2019-2030)
    4.4 Global Tagrisso (Osimertinib) Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Tagrisso (Osimertinib) Sales Value by Region
        5.1.1 Global Tagrisso (Osimertinib) Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Tagrisso (Osimertinib) Sales Value by Region (2019-2024)
        5.1.3 Global Tagrisso (Osimertinib) Sales Value by Region (2025-2030)
        5.1.4 Global Tagrisso (Osimertinib) Sales Value by Region (%), (2019-2030)
    5.2 Global Tagrisso (Osimertinib) Sales Volume by Region
        5.2.1 Global Tagrisso (Osimertinib) Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Tagrisso (Osimertinib) Sales Volume by Region (2019-2024)
        5.2.3 Global Tagrisso (Osimertinib) Sales Volume by Region (2025-2030)
        5.2.4 Global Tagrisso (Osimertinib) Sales Volume by Region (%), (2019-2030)
    5.3 Global Tagrisso (Osimertinib) Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Tagrisso (Osimertinib) Sales Value, 2019-2030
        5.4.2 North America Tagrisso (Osimertinib) Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Tagrisso (Osimertinib) Sales Value, 2019-2030
        5.5.2 Europe Tagrisso (Osimertinib) Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Tagrisso (Osimertinib) Sales Value, 2019-2030
        5.6.2 Asia Pacific Tagrisso (Osimertinib) Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Tagrisso (Osimertinib) Sales Value, 2019-2030
        5.7.2 South America Tagrisso (Osimertinib) Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Tagrisso (Osimertinib) Sales Value, 2019-2030
        5.8.2 Middle East & Africa Tagrisso (Osimertinib) Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Tagrisso (Osimertinib) Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Tagrisso (Osimertinib) Sales Value
        6.2.1 Key Countries/Regions Tagrisso (Osimertinib) Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Tagrisso (Osimertinib) Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Tagrisso (Osimertinib) Sales Value, 2019-2030
        6.3.2 United States Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Tagrisso (Osimertinib) Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Tagrisso (Osimertinib) Sales Value, 2019-2030
        6.4.2 Europe Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Tagrisso (Osimertinib) Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Tagrisso (Osimertinib) Sales Value, 2019-2030
        6.5.2 China Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Tagrisso (Osimertinib) Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Tagrisso (Osimertinib) Sales Value, 2019-2030
        6.6.2 Japan Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Tagrisso (Osimertinib) Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Tagrisso (Osimertinib) Sales Value, 2019-2030
        6.7.2 South Korea Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Tagrisso (Osimertinib) Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Tagrisso (Osimertinib) Sales Value, 2019-2030
        6.8.2 Southeast Asia Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Tagrisso (Osimertinib) Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Tagrisso (Osimertinib) Sales Value, 2019-2030
        6.9.2 India Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Tagrisso (Osimertinib) Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Company Information
        7.1.2 AstraZeneca Introduction and Business Overview
        7.1.3 AstraZeneca Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 AstraZeneca Tagrisso (Osimertinib) Product Offerings
        7.1.5 AstraZeneca Recent Development
    7.2 Incepta Pharmaceuticals Ltd
        7.2.1 Incepta Pharmaceuticals Ltd Company Information
        7.2.2 Incepta Pharmaceuticals Ltd Introduction and Business Overview
        7.2.3 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Offerings
        7.2.5 Incepta Pharmaceuticals Ltd Recent Development
    7.3 Lonza AG
        7.3.1 Lonza AG Company Information
        7.3.2 Lonza AG Introduction and Business Overview
        7.3.3 Lonza AG Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Lonza AG Tagrisso (Osimertinib) Product Offerings
        7.3.5 Lonza AG Recent Development
    7.4 Everest Pharmaceuticals
        7.4.1 Everest Pharmaceuticals Company Information
        7.4.2 Everest Pharmaceuticals Introduction and Business Overview
        7.4.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Offerings
        7.4.5 Everest Pharmaceuticals Recent Development
    7.5 Beacon Pharmaceuticals Limited
        7.5.1 Beacon Pharmaceuticals Limited Company Information
        7.5.2 Beacon Pharmaceuticals Limited Introduction and Business Overview
        7.5.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Offerings
        7.5.5 Beacon Pharmaceuticals Limited Recent Development
    7.6 Drug International Limited
        7.6.1 Drug International Limited Company Information
        7.6.2 Drug International Limited Introduction and Business Overview
        7.6.3 Drug International Limited Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Drug International Limited Tagrisso (Osimertinib) Product Offerings
        7.6.5 Drug International Limited Recent Development

 8 Industry Chain Analysis
    8.1 Tagrisso (Osimertinib) Industrial Chain
    8.2 Tagrisso (Osimertinib) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Tagrisso (Osimertinib) Sales Model
        8.5.2 Sales Channel
        8.5.3 Tagrisso (Osimertinib) Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Tagrisso (Osimertinib) Market Trends
    Table 2. Tagrisso (Osimertinib) Market Drivers & Opportunity
    Table 3. Tagrisso (Osimertinib) Market Challenges
    Table 4. Tagrisso (Osimertinib) Market Restraints
    Table 5. Global Tagrisso (Osimertinib) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Tagrisso (Osimertinib) Revenue Market Share by Company (2019-2024)
    Table 7. Global Tagrisso (Osimertinib) Sales Volume by Company (2019-2024) & (K Pcs)
    Table 8. Global Tagrisso (Osimertinib) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Tagrisso (Osimertinib) Price by Company (2019-2024) & (US$/Pcs)
    Table 10. Key Manufacturers Tagrisso (Osimertinib) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Tagrisso (Osimertinib) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Tagrisso (Osimertinib)
    Table 13. Global Tagrisso (Osimertinib) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tagrisso (Osimertinib) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Tagrisso (Osimertinib) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Tagrisso (Osimertinib) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Tagrisso (Osimertinib) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Tagrisso (Osimertinib) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Tagrisso (Osimertinib) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Tagrisso (Osimertinib) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
    Table 22. Global Tagrisso (Osimertinib) Sales Volume by Type (2019-2024) & (K Pcs)
    Table 23. Global Tagrisso (Osimertinib) Sales Volume by Type (2025-2030) & (K Pcs)
    Table 24. Global Tagrisso (Osimertinib) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Tagrisso (Osimertinib) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Tagrisso (Osimertinib) Price by Type (2019-2024) & (US$/Pcs)
    Table 27. Global Tagrisso (Osimertinib) Price by Type (2025-2030) & (US$/Pcs)
    Table 28. Global Tagrisso (Osimertinib) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Tagrisso (Osimertinib) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Tagrisso (Osimertinib) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Tagrisso (Osimertinib) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Tagrisso (Osimertinib) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Tagrisso (Osimertinib) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Pcs)
    Table 34. Global Tagrisso (Osimertinib) Sales Volume by Application (2019-2024) & (K Pcs)
    Table 35. Global Tagrisso (Osimertinib) Sales Volume by Application (2025-2030) & (K Pcs)
    Table 36. Global Tagrisso (Osimertinib) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Tagrisso (Osimertinib) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Tagrisso (Osimertinib) Price by Application (2019-2024) & (US$/Pcs)
    Table 39. Global Tagrisso (Osimertinib) Price by Application (2025-2030) & (US$/Pcs)
    Table 40. Global Tagrisso (Osimertinib) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Tagrisso (Osimertinib) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Tagrisso (Osimertinib) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Tagrisso (Osimertinib) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Tagrisso (Osimertinib) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Tagrisso (Osimertinib) Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
    Table 46. Global Tagrisso (Osimertinib) Sales Volume by Region (2019-2024) & (K Pcs)
    Table 47. Global Tagrisso (Osimertinib) Sales Volume by Region (2025-2030) & (K Pcs)
    Table 48. Global Tagrisso (Osimertinib) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Tagrisso (Osimertinib) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Tagrisso (Osimertinib) Average Price by Region (2019-2024) & (US$/Pcs)
    Table 51. Global Tagrisso (Osimertinib) Average Price by Region (2025-2030) & (US$/Pcs)
    Table 52. Key Countries/Regions Tagrisso (Osimertinib) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Tagrisso (Osimertinib) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Tagrisso (Osimertinib) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Tagrisso (Osimertinib) Sales Volume, (2019-2024) & (K Pcs)
    Table 56. Key Countries/Regions Tagrisso (Osimertinib) Sales Volume, (2025-2030) & (K Pcs)
    Table 57. AstraZeneca Company Information
    Table 58. AstraZeneca Introduction and Business Overview
    Table 59. AstraZeneca Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 60. AstraZeneca Tagrisso (Osimertinib) Product Offerings
    Table 61. AstraZeneca Recent Development
    Table 62. Incepta Pharmaceuticals Ltd Company Information
    Table 63. Incepta Pharmaceuticals Ltd Introduction and Business Overview
    Table 64. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 65. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Offerings
    Table 66. Incepta Pharmaceuticals Ltd Recent Development
    Table 67. Lonza AG Company Information
    Table 68. Lonza AG Introduction and Business Overview
    Table 69. Lonza AG Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 70. Lonza AG Tagrisso (Osimertinib) Product Offerings
    Table 71. Lonza AG Recent Development
    Table 72. Everest Pharmaceuticals Company Information
    Table 73. Everest Pharmaceuticals Introduction and Business Overview
    Table 74. Everest Pharmaceuticals Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 75. Everest Pharmaceuticals Tagrisso (Osimertinib) Product Offerings
    Table 76. Everest Pharmaceuticals Recent Development
    Table 77. Beacon Pharmaceuticals Limited Company Information
    Table 78. Beacon Pharmaceuticals Limited Introduction and Business Overview
    Table 79. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 80. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Offerings
    Table 81. Beacon Pharmaceuticals Limited Recent Development
    Table 82. Drug International Limited Company Information
    Table 83. Drug International Limited Introduction and Business Overview
    Table 84. Drug International Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 85. Drug International Limited Tagrisso (Osimertinib) Product Offerings
    Table 86. Drug International Limited Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Tagrisso (Osimertinib) Downstream Customers
    Table 90. Tagrisso (Osimertinib) Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tagrisso (Osimertinib) Product Picture
    Figure 2. Global Tagrisso (Osimertinib) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Tagrisso (Osimertinib) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Tagrisso (Osimertinib) Sales Volume (2019-2030) & (K Pcs)
    Figure 5. Global Tagrisso (Osimertinib) Sales Price (2019-2030) & (US$/Pcs)
    Figure 6. Tagrisso (Osimertinib) Report Years Considered
    Figure 7. Global Tagrisso (Osimertinib) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Tagrisso (Osimertinib) Players Sales Volume Ranking (2023) & (K Pcs)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tagrisso (Osimertinib) Revenue in 2023
    Figure 10. Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 40 mg Picture
    Figure 12. 80 mg Picture
    Figure 13. Global Tagrisso (Osimertinib) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Tagrisso (Osimertinib) Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Tagrisso (Osimertinib) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 16. Global Tagrisso (Osimertinib) Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Tagrisso (Osimertinib) Price by Type (2019-2030) & (US$/Pcs)
    Figure 18. Product Picture of Locally Advanced NSCLC
    Figure 19. Product Picture of Metastatic NSCLC
    Figure 20. Product Picture of Other
    Figure 21. Global Tagrisso (Osimertinib) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Tagrisso (Osimertinib) Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Tagrisso (Osimertinib) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 24. Global Tagrisso (Osimertinib) Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Tagrisso (Osimertinib) Price by Application (2019-2030) & (US$/Pcs)
    Figure 26. North America Tagrisso (Osimertinib) Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Tagrisso (Osimertinib) Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Tagrisso (Osimertinib) Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Tagrisso (Osimertinib) Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Tagrisso (Osimertinib) Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Tagrisso (Osimertinib) Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Tagrisso (Osimertinib) Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Tagrisso (Osimertinib) Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Tagrisso (Osimertinib) Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Tagrisso (Osimertinib) Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Tagrisso (Osimertinib) Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Tagrisso (Osimertinib) Sales Volume (%), (2019-2030)
    Figure 38. United States Tagrisso (Osimertinib) Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Tagrisso (Osimertinib) Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Tagrisso (Osimertinib) Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Tagrisso (Osimertinib) Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Tagrisso (Osimertinib) Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Tagrisso (Osimertinib) Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Tagrisso (Osimertinib) Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Tagrisso (Osimertinib) Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Tagrisso (Osimertinib) Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Tagrisso (Osimertinib) Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Tagrisso (Osimertinib) Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Tagrisso (Osimertinib) Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Tagrisso (Osimertinib) Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Tagrisso (Osimertinib) Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Tagrisso (Osimertinib) Sales Value by Application (%), 2023 VS 2030
    Figure 59. Tagrisso (Osimertinib) Industrial Chain
    Figure 60. Tagrisso (Osimertinib) Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Description

Tagrisso, also known by its generic name Osimertinib, is a medication used to treat certain types of non-small cell lung cancer (NSCLC). It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs), which work by blocking the action of certain proteins involved in the growth and spread of cancer cells. Tagrisso is specifically used for the treatment of NSCLC that has certain mutations in the epidermal growth factor receptor (EGFR) gene.

The global market for Tagrisso (Osimertinib) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Tagrisso (Osimertinib) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tagrisso (Osimertinib) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Tagrisso (Osimertinib) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Tagrisso (Osimertinib) include AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited and Drug International Limited, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Tagrisso (Osimertinib), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tagrisso (Osimertinib) by region & country, by Type, and by Application.

The Tagrisso (Osimertinib) market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tagrisso (Osimertinib).

Market Segmentation